Breaking News

Botanical Solution Inc. to Supply Pharma Grade QS-21 Vaccine Adjuvant

Secures $3.3 million in funding with second round planned for Spring 2021 to bolster growth.

By: Contract Pharma

Contract Pharma Staff

Botanical Solution Inc. (BSI), a provider of advanced botanical materials for pharma and agriculture applications, has secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021. Funds will be used to discover and develop novel botanical products that are sustainable, highly consistent and cost effective, according to the company.   BSI says its proprietary biotechnology platform eliminates the major barriers, such as supply and quality issues, whic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters